EMMYON, INC.

Metabolic Health

CORALVILLE, United States · Founded 2016 · $6.0M raised

Headquarters
CORALVILLE, Iowa
Employees
1–10
Founded
2016
Business Model
B2B
Website
emmyon.com
Total Funding
$6.0M
Last Round
GrantAug 2025
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Emmyon, Inc. is a privately-held biotechnology corporation with expertise in skeletal muscle biology, metabolism, and small molecule discovery. Its business model is to discover small molecules with beneficial effects for human and animal health, then commercialize those molecules via out-licensing agreements with consumer-facing companies, alongside R&D collaborations with commercialization partners. Emmyon's portfolio of patent-protected technology includes natural dietary compounds such as ursolic acid and tomatidine, as well as novel compounds.

Summary

EMMYON, INC. is a Biotech company based in CORALVILLE, United States, founded in 2016. It has raised $6.0M in total across 6 rounds, most recently a Grant round in Aug 2025. Investors include National Cancer Institute, HHS and National Institutes of Health.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase II (NIH)Aug 2025
$1.0M

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EMMYON, INC. on Indexed.vc
<a href="https://indexed.vc/companies/emmyon-inc"><img src="https://indexed.vc/api/badge/company/emmyon-inc" alt="EMMYON, INC. on Indexed.vc" width="260" height="76" /></a>